Follow The Filings

STE Steris PLC

Health Care, filed as STERIS PLC (SHS USD), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 1 Owner
  • $20K
  • 1 add

In 2026 Q2 First Eagle Investment Management added to Steris.

Who owns STE

Sorted by value, long equity only, as of 2026 Q2.

History
First Eagle Investment Management <0.01% Add +427.8% 95 $20K History

Insider trades

Open-market buys and sales by STE's executives, directors and 10% owners in the last 12 months, from their Form 4s

All STE insider trades
  • None no insider bought on the open market
  • $8.6M sold by 6 insiders outside a trading plan
  • $1.2M sold by 2 insiders under 10b5-1 plans
  1. Mohsen Sohi Director
    Sale
    $957K 4,058 shares at $235.78 14% of stake
    Traded Aug 12 Filed Aug 12
  2. John Adam Zangerle Sr. VP, Gen Counsel, and Sec.
    Planned sale
    $297K 1,419 shares at $209.28 3.9% of stake
    Traded Jun 15 Filed Jun 16
  3. Daniel A Carestio CEO
    Planned sale
    $947K 4,428 shares at $213.82 6.5% of stake
    Traded Jun 4–5 Filed Jun 8
  4. Richard C Breeden Director
    Sale
    $310K 1,481 shares at $209.51 3.7% of stake
    Traded Jun 2 Filed Jun 4
  5. Cynthia L Feldmann Director
    Sale
    $735K 3,098 shares at $237.21 82% of stake
    Traded Mar 5 Filed Mar 6
  6. Julia Madsen Sr. VP and GM, Life Sciences
    Sale
    $1.3M 5,008 shares at $262.00 32% of stake
    Traded Nov 21, 2025 Filed Nov 25, 2025
  7. Renato Tamaro V.P. & Corporate Treasurer
    Sale
    $1.3M 5,036 shares at $257.55 47% of stake
    Traded Nov 18, 2025 Filed Nov 20, 2025
  8. John Adam Zangerle Sr. VP, Gen Counsel, and Sec.
    Sale
    $4M 15,000 shares at $265.14 31% of stake
    Traded Nov 11, 2025 Filed Nov 13, 2025

Also filed in the last 12 months, not counted as buying or selling: 33 share withholdings for taxes, 10 stock grants, and 9 option exercises.

Congress

5 members of Congress traded STE in the last three years: 11 buys and 8 sales. 5 members listed it in 2025 annual reports.

All Congress trades
  1. Kevin Hern R-OK-1 Sell $15K–$50K Sep 15 filed Sep 25
  2. April McClain Delaney D-MD-6Child Sell $100K–$250K Aug 25 filed Sep 9
  3. Jared Moskowitz D-FL-23 Sell $1K–$15K Jul 13 filed Aug 27
  4. April McClain Delaney D-MD-6Child Partial sale $1K–$15K Jul 31 filed Aug 3
  5. April McClain Delaney D-MD-6Child Partial sale $1K–$15K Jul 29 filed Aug 3
  6. April McClain Delaney D-MD-6Child Partial sale $1K–$15K Jul 27 filed Aug 3

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
10-Q
8-K 1.01,1.02,2.03,9.01
8-K 2.02,2.05,9.01
8-K 1.01
10-Q
8-K/A 5.02
8-K 5.07
8-K 2.02,2.05,9.01
DEF 14A
DEFA14A

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $4.96B $5.14B $5.46B $5.94B
Gross profit $2.16B $2.22B $2.4B $2.63B
Gross margin * 43.6% 43.2% 44.0% 44.2%
Net income $107.03M $378.24M $614.64M $782.3M
Net margin * 2.2% 7.4% 11.3% 13.2%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $2.01B $2.87B $2B $2.39B
Total non-current assets * $8.81B $8.19B $8.15B $8.34B
Total assets $10.82B $11.06B $10.15B $10.74B
Total current liabilities $0.862B $0.931B $1.02B $1.14B
Total non-current liabilities * $3.87B $3.82B $2.51B $2.4B
Total equity $6.08B $6.3B $6.6B $7.18B

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $0.757B $0.973B $1.15B $1.34B
Cash from investing -$383.33M -$887.36M $388.77M -$512.5M
Cash from financing -$0.499B -$0.085B -$1.57B -$0.568B
Net change in cash -$139.96M -$1.34M -$35.32M $267.9M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf